Javascript must be enabled to continue!
Abstract 273: Exploring trends in LVO EVT treatment of fringe patients by race
View through CrossRef
Introduction
Following the publication of the randomized clinical trials in 2015 and 2018 on endovascular stroke therapy (EVT), procedural utilization has increased. Guidelines have since been developed and followed regarding cut‐offs for patient treatment eligibility. Here, we explore the trends in EVT treatment of patients categorized as “fringe” patients by race.
Methods
We performed a retrospective cross‐sectional analysis using the SVIN Registry with records from 2010 to 2021. This dataset includes all LVO AIS patients that underwent EVT. Patients were categorized as “fringe” or “non‐fringe” based on NIHSS (<6), ASPECTS (<6), pMRS (>1), proximal vs distal occlusion, last known well to arrival time (>24 hours), and age (>85). Fringe cutoffs were determined using typical guidelines. Outcomes were compared between White patients and Black/African American patients to determine trends in treating fringe patients with EVT. Chi‐squared analyses were utilized for outcomes.
Results
Among the 7,018 patients 4,791 patients were White and 1,821 patients were black. Median age was 69 (IQR: 58‐79). Median NIHSS was 17 (IQR: 11‐22). Focusing on the White and Black/AA patient population, a greater percentage of LVO patients that underwent EVT and were considered “fringe” were Black/AA patients (66% vs 71%). We also found that there are significant differences among these fringe categories categories: age, (20% vs 7.9%, p<0.001 white vs black), proximal occlusion (52% vs 58%, p<0.001, white vs black), and of having sICH (4.2% vs 2.8% p=0.03 white vs black). Comparing fringe categories between races, White patients were more likely to be >85 years of age, have a distal occlusion, and have sICH than Black/AA patients. Of note, while there was not a significant difference in last known well to CSC arrival times between the race groups, White patients were more likely to receive tPA (37% vs 30%, p<0.001, White vs Black/AA).
Conclusion
These findings indicate that there may be a presence of racial bias in treatment decision‐ making that should be further explored. Further, there is proof that indications for EVT interventions are being expanded past guidelines in order to provide treatment for a wider range of patients.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 273: Exploring trends in LVO EVT treatment of fringe patients by race
Description:
Introduction
Following the publication of the randomized clinical trials in 2015 and 2018 on endovascular stroke therapy (EVT), procedural utilization has increased.
Guidelines have since been developed and followed regarding cut‐offs for patient treatment eligibility.
Here, we explore the trends in EVT treatment of patients categorized as “fringe” patients by race.
Methods
We performed a retrospective cross‐sectional analysis using the SVIN Registry with records from 2010 to 2021.
This dataset includes all LVO AIS patients that underwent EVT.
Patients were categorized as “fringe” or “non‐fringe” based on NIHSS (<6), ASPECTS (<6), pMRS (>1), proximal vs distal occlusion, last known well to arrival time (>24 hours), and age (>85).
Fringe cutoffs were determined using typical guidelines.
Outcomes were compared between White patients and Black/African American patients to determine trends in treating fringe patients with EVT.
Chi‐squared analyses were utilized for outcomes.
Results
Among the 7,018 patients 4,791 patients were White and 1,821 patients were black.
Median age was 69 (IQR: 58‐79).
Median NIHSS was 17 (IQR: 11‐22).
Focusing on the White and Black/AA patient population, a greater percentage of LVO patients that underwent EVT and were considered “fringe” were Black/AA patients (66% vs 71%).
We also found that there are significant differences among these fringe categories categories: age, (20% vs 7.
9%, p<0.
001 white vs black), proximal occlusion (52% vs 58%, p<0.
001, white vs black), and of having sICH (4.
2% vs 2.
8% p=0.
03 white vs black).
Comparing fringe categories between races, White patients were more likely to be >85 years of age, have a distal occlusion, and have sICH than Black/AA patients.
Of note, while there was not a significant difference in last known well to CSC arrival times between the race groups, White patients were more likely to receive tPA (37% vs 30%, p<0.
001, White vs Black/AA).
Conclusion
These findings indicate that there may be a presence of racial bias in treatment decision‐ making that should be further explored.
Further, there is proof that indications for EVT interventions are being expanded past guidelines in order to provide treatment for a wider range of patients.
Related Results
Abstract TP56: Low Cost, Portable Electroencephalograph May Improve The Accuracy Of Prehospital Stroke Diagnosis And Detection Of Large Vessel Occlusion
Abstract TP56: Low Cost, Portable Electroencephalograph May Improve The Accuracy Of Prehospital Stroke Diagnosis And Detection Of Large Vessel Occlusion
Accurate and timely prehospital stroke diagnosis and detection of large vessel occlusion (LVO) are essential to ensure stroke patients are transported to hospitals that offer emerg...
Abstract TP72: Large Core Trials – Game Changing for Stroke Care or falling on deaf ears?
Abstract TP72: Large Core Trials – Game Changing for Stroke Care or falling on deaf ears?
Introduction:
After publication of Large core trials that offered evidence that endovascular therapies (EVT) was more beneficial versus medical management for acute isc...
Abstract WP039: LVO Transfer Process within the hospital system
Abstract WP039: LVO Transfer Process within the hospital system
Background:
Reperfusion with endovascular thrombectomy (EVT) is a time-sensitive procedure that improves functional outcomes in acute LVO stroke. Per the Americ...
Abstract Number ‐ 206: Evaluation of Disparities in Endovascular Treatment Times for Hispanics versus Non‐Hispanics
Abstract Number ‐ 206: Evaluation of Disparities in Endovascular Treatment Times for Hispanics versus Non‐Hispanics
Introduction
Endovascular therapy (EVT) within 24 hours from last known well (LKW) improves functional outcomes in acute ischemic stroke (AIS) with large vessel occlusi...
Abstract TMP30: Combining the Los Angeles Motor Scale and the Muse Portable Electroencephalography System Improves the Accuracy of Large Vessel Occlusion Detection in Acute Stroke Syndrome.
Abstract TMP30: Combining the Los Angeles Motor Scale and the Muse Portable Electroencephalography System Improves the Accuracy of Large Vessel Occlusion Detection in Acute Stroke Syndrome.
Background:
The prehospital scales have been developed to identify stroke patients with large vessel occlusion (LVO) to facilitate rapid transport to appropriate stroke...
Anticoagulation Therapy in Endovascular Thrombectomy Patients With Large‐Vessel Occlusion Caused by Cardioembolism
Anticoagulation Therapy in Endovascular Thrombectomy Patients With Large‐Vessel Occlusion Caused by Cardioembolism
Background
In patients with ischemic stroke, cardioembolism, predominantly caused by atrial fibrillation (AF), is a leading preventable cause of large‐vessel occlusion ...
Viz LVO versus Rapid LVO in detection of large vessel occlusion on CT angiography for acute stroke
Viz LVO versus Rapid LVO in detection of large vessel occlusion on CT angiography for acute stroke
BackgroundEndovascular thrombectomy improves outcomes and reduces mortality for large vessel occlusion (LVO) and is time-sensitive. Computer automation may aid in the early detecti...
Changes in Patient Volumes and Outcomes After Adding Thrombectomy Capability
Changes in Patient Volumes and Outcomes After Adding Thrombectomy Capability
Background and Purpose:
With the rising demand for endovascular thrombectomy (EVT) and introduction of thrombectomy-capable stroke centers (TSC), there is inter...

